RTHP-23. ADJUVANT THERAPY FOR HIGH-RISK WHO GRADE II OLIGODENDROGLIOMA AFTER RTOG 9802: A SURVEY OF CURRENT PRACTICE

PURPOSE: RTOG 9802 long-term results (NEJM, April 2016) demonstrated significant improvements in overall survival with chemoradiotherapy (CRT) compared to radiotherapy alone, for patients with low-grade, high-risk supratentorial oligodendroglioma. Before publication of RTOG 9802, many such patients...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Neuro Oncol
Auteurs principaux: Fakhreddine, Mohamad, Parameswaran, Anand, Floyd, John, Brenner, Andrew, Crownover, Richard
Format: Artigo
Langue:Inglês
Publié: Oxford University Press 2017
Sujets:
Abstracts
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC5692294/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nox168.906
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires